Dr. Zong-Ming Li of the UArizona College of Medicine – Tucson has been honored by the American Society of Mechanical Engineers for his work on human hands.

Dr. Laura Mercer was the driving force behind the passage of a new law expanding access to prescription birth control.

Infectious disease experts share their thoughts on the CDC’s updated guidance for wearing masks. Elizabeth Connick, MD, professor and chief of the division of infectious diseases at the College of Medicine – Tucson and member of Healio's Infectious Disease News Editorial Board, is quoted.

As we head into a third year of the pandemic, Kristen Pogreba-Brown, PhD, MPH, assistant professor and epidemiologist at the Mel and Enid Zuckerman College of Public Health, says it's too early to tell if we are on the precipice of the coronavirus becoming endemic.

The Migrant Health Interest Group at the UArizona College of Medicine – Phoenix is one example of how people within the academic medicine community — from students to administrators — are working to provide medical services to immigrants who face significant barriers to accessing the traditional health care system in the United States.

Multiple new health care initiatives will leverage strengths developed during the pandemic and coincide with the academic medical center’s 55th year.

Arizona continues to average more than 20,000 COVID-19 infections per day — more than double the average number of daily cases reported during last winter's peak. Joe Gerald, MD, PhD, associate professor of public health policy at the Mel and Enid Zuckerman College of Public Health, said the record-high case numbers are probably a fraction of cases actually out there.

People who contract Omicron will have even broader immune responses, said Deepta Bhattacharya, PhD, an immunologist at the College of Medicine – Tucson. Though its constellation of mutations is unique, it is made up of individual changes that have been seen in other variants. “

University of Arizona Health Sciences researchers discovered a potential treatment to reduce the risk of post-stroke dementia, which may be influenced by the immune response to dead brain tissue left in the wake of a stroke, according to a study published in the Journal of Neuroscience.